ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pimozide Tablets 1 mg and 2 mg.
ANI Pharmaceuticals trades at 10x forward earnings with a $93 target, but execution in Cortrophin and ophthalmology recovery ...
Zacks Investment Research on MSN
Here's why ANI Pharmaceuticals (ANIP) is a strong growth stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Investors in ANI Pharmaceuticals Inc (Symbol: ANIP) saw new options become available today, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...
ANI Pharmaceuticals’ ANIP rare disease franchise spearheaded its growth in 2025. This robust growth was fueled by the strong performance of its ACTH-based injection Cortrophin Gel. Cortrophin Gel ...
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg and 300 mg. ANI’s Carbamazepine Extended-Release ...
List today: Subsea 7 SUBCY: This company, which operates as an engineering, construction and services contractor to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results